VivoSim Labs Statistics
Total Valuation
VivoSim Labs has a market cap or net worth of $2.11 million. The enterprise value is -$5.94 million.
| Market Cap | 2.11M |
| Enterprise Value | -5.94M |
Important Dates
The last earnings date was Thursday, November 12, 2026, after market close.
| Earnings Date | Nov 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
VivoSim Labs has 16.59 million shares outstanding. The number of shares has increased by 227.54% in one year.
| Current Share Class | 16.59M |
| Shares Outstanding | 16.59M |
| Shares Change (YoY) | +227.54% |
| Shares Change (QoQ) | +213.87% |
| Owned by Insiders (%) | 2.61% |
| Owned by Institutions (%) | 0.88% |
| Float | 16.15M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 15.62 |
| Forward PS | n/a |
| PB Ratio | 0.32 |
| P/TBV Ratio | 0.29 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.50, with a Debt / Equity ratio of 0.07.
| Current Ratio | 3.50 |
| Quick Ratio | 3.23 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1,001.00 |
Financial Efficiency
Return on equity (ROE) is -143.54% and return on invested capital (ROIC) is -94.61%.
| Return on Equity (ROE) | -143.54% |
| Return on Assets (ROA) | -76.57% |
| Return on Invested Capital (ROIC) | -94.61% |
| Return on Capital Employed (ROCE) | -165.87% |
| Weighted Average Cost of Capital (WACC) | 10.67% |
| Revenue Per Employee | $9,000 |
| Profits Per Employee | -$684,533 |
| Employee Count | 15 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, VivoSim Labs has paid $3,000 in taxes.
| Income Tax | 3,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -94.38% in the last 52 weeks. The beta is 1.56, so VivoSim Labs's price volatility has been higher than the market average.
| Beta (5Y) | 1.56 |
| 52-Week Price Change | -94.38% |
| 50-Day Moving Average | 0.19 |
| 200-Day Moving Average | 0.99 |
| Relative Strength Index (RSI) | 35.98 |
| Average Volume (20 Days) | 1,253,007 |
Short Selling Information
The latest short interest is 649,569, so 3.92% of the outstanding shares have been sold short.
| Short Interest | 649,569 |
| Short Previous Month | 598,424 |
| Short % of Shares Out | 3.92% |
| Short % of Float | 4.02% |
| Short Ratio (days to cover) | 0.67 |
Income Statement
In the last 12 months, VivoSim Labs had revenue of $135,000 and -$10.27 million in losses. Loss per share was -$1.53.
| Revenue | 135,000 |
| Gross Profit | -4.11M |
| Operating Income | -12.01M |
| Pretax Income | -10.27M |
| Net Income | -10.27M |
| EBITDA | -11.84M |
| EBIT | -12.01M |
| Loss Per Share | -$1.53 |
Balance Sheet
The company has $8.56 million in cash and $512,000 in debt, with a net cash position of $8.05 million or $0.49 per share.
| Cash & Cash Equivalents | 8.56M |
| Total Debt | 512,000 |
| Net Cash | 8.05M |
| Net Cash Per Share | $0.49 |
| Equity (Book Value) | 7.24M |
| Book Value Per Share | 0.40 |
| Working Capital | 6.72M |
Cash Flow
In the last 12 months, operating cash flow was -$10.20 million and capital expenditures -$85,000, giving a free cash flow of -$10.29 million.
| Operating Cash Flow | -10.20M |
| Capital Expenditures | -85,000 |
| Depreciation & Amortization | 170,000 |
| Net Borrowing | -353,000 |
| Free Cash Flow | -10.29M |
| FCF Per Share | -$0.62 |
Margins
| Gross Margin | n/a |
| Operating Margin | -8,897.78% |
| Pretax Margin | -7,603.70% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
VivoSim Labs does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -227.54% |
| Shareholder Yield | -227.54% |
| Earnings Yield | -1,201.18% |
| FCF Yield | -487.87% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
The last stock split was on March 21, 2025. It was a reverse split with a ratio of 1:12.
| Last Split Date | Mar 21, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:12 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |